IL160938A0 - Coniosulphides and their derivatives, processes for preparing them, and their use as pharmaceuticals - Google Patents

Coniosulphides and their derivatives, processes for preparing them, and their use as pharmaceuticals

Info

Publication number
IL160938A0
IL160938A0 IL16093802A IL16093802A IL160938A0 IL 160938 A0 IL160938 A0 IL 160938A0 IL 16093802 A IL16093802 A IL 16093802A IL 16093802 A IL16093802 A IL 16093802A IL 160938 A0 IL160938 A0 IL 160938A0
Authority
IL
Israel
Prior art keywords
coniosulphides
pharmaceuticals
derivatives
preparing
processes
Prior art date
Application number
IL16093802A
Other languages
English (en)
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of IL160938A0 publication Critical patent/IL160938A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P11/00—Preparation of sulfur-containing organic compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/001—Amines; Imines
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/02—Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL16093802A 2001-09-22 2002-09-06 Coniosulphides and their derivatives, processes for preparing them, and their use as pharmaceuticals IL160938A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10146737A DE10146737A1 (de) 2001-09-22 2001-09-22 Coniosulfide und deren Derivate, Verfahren zu ihrer Herstellung und Verwendung als Arzneimittel
PCT/EP2002/009977 WO2003029495A2 (fr) 2001-09-22 2002-09-06 Coniosulfures et derives, leurs procedes de production et leur utilisation en tant que medicaments

Publications (1)

Publication Number Publication Date
IL160938A0 true IL160938A0 (en) 2004-08-31

Family

ID=7699903

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16093802A IL160938A0 (en) 2001-09-22 2002-09-06 Coniosulphides and their derivatives, processes for preparing them, and their use as pharmaceuticals
IL160938A IL160938A (en) 2001-09-22 2004-03-18 Coniosulphides and their derivatives, processes for preparing them and their use as pharmaceuticals

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL160938A IL160938A (en) 2001-09-22 2004-03-18 Coniosulphides and their derivatives, processes for preparing them and their use as pharmaceuticals

Country Status (12)

Country Link
EP (2) EP1903033B1 (fr)
JP (2) JP4287744B2 (fr)
AR (1) AR036554A1 (fr)
AT (2) ATE430131T1 (fr)
AU (1) AU2002339519B2 (fr)
CA (1) CA2461033C (fr)
DE (3) DE10146737A1 (fr)
ES (2) ES2326563T3 (fr)
IL (2) IL160938A0 (fr)
MX (1) MXPA04001951A (fr)
PE (1) PE20030466A1 (fr)
WO (1) WO2003029495A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2362866E (pt) * 2008-11-11 2015-10-26 Signum Biosciences Inc Compostos de isoprenila e métodos dos mesmos
JP7318948B2 (ja) * 2018-04-13 2023-08-01 国立大学法人京都大学 微生物由来化合物を用いたアルツハイマー病の予防、治療、または診断薬

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9210393D0 (en) * 1992-05-15 1992-07-01 Merck Sharp & Dohme Therapeutic agents
FR2740454B1 (fr) * 1995-10-26 1997-11-21 Rhone Poulenc Rorer Sa Peptides capables d'inhiber l'endocytose de l'app et sequences nucleotidiques correspondantes
WO1998021327A1 (fr) * 1996-11-08 1998-05-22 Rhone-Poulenc Rorer S.A. Peptides capables d'inhiber l'endocytose de l'app et sequences nucleotidiques correspondantes
EP1257642B1 (fr) * 2000-02-10 2008-11-26 Aventis Pharma S.A. Partenaires du domaine ptb1 de fe65, preparation et utilisations
DE10060810A1 (de) 2000-12-07 2002-06-20 Aventis Pharma Gmbh Coniosetin und Derivate davon, Verfahren zur Herstellung und Verwendung derselben

Also Published As

Publication number Publication date
DE50212774D1 (de) 2008-10-23
WO2003029495A2 (fr) 2003-04-10
WO2003029495A3 (fr) 2004-02-26
ATE430131T1 (de) 2009-05-15
PE20030466A1 (es) 2003-07-08
AR036554A1 (es) 2004-09-15
AU2002339519B2 (en) 2007-02-08
EP1903033A1 (fr) 2008-03-26
ES2326563T3 (es) 2009-10-14
ATE407942T1 (de) 2008-09-15
ES2314107T3 (es) 2009-03-16
EP1474440A2 (fr) 2004-11-10
MXPA04001951A (es) 2004-06-07
JP4287744B2 (ja) 2009-07-01
IL160938A (en) 2010-11-30
JP2005504131A (ja) 2005-02-10
CA2461033A1 (fr) 2003-04-10
DE50213512D1 (de) 2009-06-10
EP1903033B1 (fr) 2009-04-29
DE10146737A1 (de) 2003-04-10
EP1474440B1 (fr) 2008-09-10
JP2009149662A (ja) 2009-07-09
CA2461033C (fr) 2011-12-06

Similar Documents

Publication Publication Date Title
TWI347201B (en) Pharmaceutical products,uses thereof and methods for preparing the same
IL160440A (en) Dihydropteridinones, method for producing the same and the use thereof as medicaments
AU2002365516A1 (en) Benzamide derivatives, processes for their preparation, and their pharmaceutical use
HUP0401648A3 (en) 6-hydroxy isoflavon compounds, their derivatives and medicaments involving the same
HUP0402264A3 (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines process for preparing them, pharmaceutical compositions containing them and use thereof
IL191790B (en) The history of xanthine, their production and their use as medicines
IL165977A (en) Substituted pyrimidinylaminobenzamides , process for the preparation thereof and pharmaceutical compositions comprising the same
HUP0303729A3 (en) Novel heteroaryl derivatives and the use thereof as pharmaceuticals and process for their preparation
TWI319764B (en) Mercaptoacetylamide derivatives, a process for their preparation and their use
MXPA03006538A (es) Nuevos derivados de urea, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion.
MXPA03008630A (es) Derivados de arilisoxazolinas, procedimientos para su preparacion y su utilizacion como agentes plaguicidas.
PL350190A1 (en) Epothilon derivatives, method for the production and the use thereof as pharmaceuticals
IL162316A0 (en) Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition t
IL159570A0 (en) Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
MXPA03006478A (es) Derivados de cromano, procedimiento para su preparacion y su uso como agentes antitumorales.
IL164248A0 (en) Acyl-3-carboxyphenylurea derivatives, processes for preparing them and their use
MXPA03006249A (es) Derivados de 2-arilimino-2,3-dihidrotiazoles, sus procesos de preparacion y su uso terapeutico.
AU2002233407A1 (en) 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
IL164815A0 (en) Halosulfonylbenzoyl halides, processes for their preparation and their use for preparing substitutedphenylsulfonylureas
IL160606A0 (en) C2-substituted indan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals
IL160938A0 (en) Coniosulphides and their derivatives, processes for preparing them, and their use as pharmaceuticals
IL160608A0 (en) C2-substituted indan-1-ones and their derivatives, processes for their preparation and their use as pharmaceuticals
IL159561A0 (en) Eurotinones and derivatives thereof, processes for preparing them, and their use
IL157793A0 (en) Caloporoside derivatives, methods for the production thereof and their use
AU2003264894A8 (en) Novel method for preparing alpha-glycosylceramides, novel alpha-glycosylceramide derivatives and their uses